Immunology
Latest Content
Phase 2 trials underway for new pneumococcal disease vaccine
Trials are underway on a £3.2 million-funded new vaccine to tackle the presence pneumococcal disease, a leading preventable cause of child deaths.
News
Phase 2 trials underway for new pneumococcal disease vaccine
Trials are underway on a £3.2 million-funded new vaccine to tackle the presence pneumococcal disease, a leading preventable cause of child deaths.
In Depth
E. coli K-12 turns 100 this year
While not your most obvious candidate for centenary celebrations, Brittany Niccum explains why we should commemorate the isolation of E. coli K-12 strain – arguably one of the most thoroughly studied…
Comment And Analysis
Gut reaction
Public interest in the significance of the microbiome has been increasing but until now testing has not always been sufficiently rigorous, says Jeremy Wilkinson.
Interviews
Diagnosing dysbiosis – understanding imbalance in human gut microbiota
Dysbiosis describes imbalance in healthy gut bacteria... but what is a healthy gut? We ask Christina Casén to explain how such a complex and changeable ecology can be interpreted well enough to diagn…
